Lobbying Affiliate: MML&K Government Solutions
{ Banner Image }

Healthcare Law Blog

Comprehensive Healthcare law services.
It's kind of our bag.

Contact Us

* Indicates a required field.

Categories

McBrayer Blogs

Related Blogs

Showing 3 posts tagged Kentucky Board of Nursing.

Kentucky Healthcare Providers: SB 150 Gives Some Liability Buffer and More

In the midst of the COVID-19 crisis, there is still good news to be found for healthcare providers. On March 30th, Gov. Beshear signed Senate Bill 150, a broad coronavirus response measure that touches on everything from licensing fees to alcohol sales.  Tucked into the bill is a provision that limits the liability of healthcare providers who treat COVID-19 patients in good faith. More >

Kentucky Board of Nursing Issues Advisory on Nurse Practitioner Prescribing During State of Emergency, Pushes Telehealth

Following the Kentucky Board of Medical Licensure’s Advisory, the Kentucky Board of Nursing issued advisory guidance regarding prescribing practices for Nurse Practitioners.

The guidance begins with a reminder of prescribing limits per the schedule of the drug prescribed, then immediately states that APRNs may utilize telehealth when prescribing controlled substances per 201 KAR 20:520. The good faith examination required to establish the provider-patient relationship under KRS 218A.010(4) can now, under the present emergency, be accomplished via telehealth. The definition of telehealth includes interactive audio, video, or other electronic media, and, as the Board points out, telephones.
More >

Compliance: Include Prescribing Practices!

Since the implementation of House Bill 1 in 2012, the restrictions on prescribing controlled substances have become more and more stringent, which is a response to the opioid epidemic sweeping Kentucky and the nation. The Cabinet for Health and Family Services, the Kentucky Board of Medical Licensure, the Kentucky Board of Nursing, and the Kentucky Board of Pharmacy are vigilant in policing prescribing practices and have tools through KASPER to closely monitor the prescribing practices of physicians and other practitioners. With the addition of new medications like Gabapentin to the controlled substances hit list, practitioners must be particularly careful to ensure that their prescribing is consistent with regulatory requirements, particularly when patients have been on this medication previously.   Physicians and practitioners must continually monitor compliance as even a minor violation can give rise to investigations, complaints and regulatory penalties.  Assessment of regulatory penalties, even when characterized as “Agreed Orders,” can have devastating consequences for physicians and practitioners’ practices and ability to maintain provider contracts, including Medicare and Medicaid. More >

Lexington, KYLouisville, KYFrankfort, KY: MML&K Government SolutionsWashington, D.C.